drugset / Trial / NCT01078844

Memantine in Adult Autism Spectrum Disorder

NCT01078844

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to see if memantine is helpful in managing problematic symptoms in adults with autism, Asperger's disorder, or Pervasive Developmental Disorder not otherwise specified (NOS).

Timeline

Start
2010-02
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Memantine Unknown 5 mg
Comparator Memantine Unknown 20 mg